Yanagi Y, Tishon A, Lewicki H, Cubitt B A, Oldstone M B
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037.
J Virol. 1992 Apr;66(4):2527-31. doi: 10.1128/JVI.66.4.2527-2531.1992.
Cytotoxic T lymphocytes (CTL) recognize virus peptide fragments complexed with class I major histocompatibility complex (MHC) molecules on the surface of virus-infected cells. Recognition is mediated by a membrane-bound T-cell receptor (TCR) composed of alpha and beta chains. Studies of the CTL response to lymphocytic choriomeningitis virus (LCMV) in H-2b mice have revealed that three distinct viral epitopes are recognized by CTL of the H-2b haplotype and that all of the three epitopes are restricted by the Db MHC molecule. The immunodominant Db-restricted CTL epitope, located at LCMV glycoprotein amino acids 278 to 286, was earlier noted to be recognized by TCRs that consistently contained V alpha 4 segments but had heterogeneous V beta segments. Here we show that CTL clones recognizing the other two H-2Db-restricted epitopes, LCMV glycoprotein amino acids 34 to 40 and nucleoprotein amino acids 397 to 407 (defined in this study), utilize TCR alpha chains which do not belong to the V alpha 4 subfamily. Hence, usage of V alpha and V beta in the TCRs recognizing peptide fragments from one virus restricted by a single MHC molecule is not sufficiently homogeneous to allow manipulation of the anti-viral CTL response at the level of TCRs. The diversity of anti-viral CTL likely provides the host with a wider option for attacking virus-infected cells and prevents the emergence of virus escape mutants that might arise if TCRs specific for the virus were homogeneous.
细胞毒性T淋巴细胞(CTL)识别与病毒感染细胞表面的I类主要组织相容性复合体(MHC)分子结合的病毒肽片段。识别由由α链和β链组成的膜结合T细胞受体(TCR)介导。对H-2b小鼠中淋巴细胞性脉络丛脑膜炎病毒(LCMV)的CTL反应的研究表明,H-2b单倍型的CTL识别三个不同的病毒表位,并且所有这三个表位都受Db MHC分子的限制。位于LCMV糖蛋白氨基酸278至286处的免疫显性Db限制性CTL表位,较早前被注意到可被始终包含Vα4片段但具有异质Vβ片段的TCR识别。在这里,我们表明识别其他两个H-2Db限制性表位(LCMV糖蛋白氨基酸34至40和核蛋白氨基酸397至407,本研究中定义)的CTL克隆利用不属于Vα4亚家族的TCRα链。因此,在识别由单个MHC分子限制的一种病毒的肽片段的TCR中,Vα和Vβ的使用不够均匀,无法在TCR水平上操纵抗病毒CTL反应。抗病毒CTL的多样性可能为宿主提供了更广泛的选择来攻击病毒感染的细胞,并防止了如果针对该病毒的TCR是同质的可能出现的病毒逃逸突变体的出现。